Use the keywords feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
JOURNAL ARTICLE
Min Ji Kim, Won Lee
BACKGROUND: Nurses are the last safeguard against and have the final opportunity to prevent medication errors (MEs) and play a vital role in patient safety by managing medications. OBJECTIVE: This study described the characteristics of medical dispute cases, medication information, and stage and types of MEs in Korea. METHODS: We performed a descriptive analysis of 27 medical dispute cases related to MEs in nursing care in Korea. RESULTS: Around 77...
November 15, 2022: International Journal of Risk & Safety in Medicine
#2
REVIEW
Anna Nevalainen, Olli Nevalainen
BACKGROUND: Pharmacovigilance risk signals have proposed a relationship between the use of acid-suppressive medications and the development of certain autoimmune and immune-mediated inflammatory diseases. OBJECTIVE: A systematic review and a meta-analysis was performed. METHODS: We reviewed MEDLINE (Ovid) and Scopus for comparative observational studies between these diseases and previous exposure to proton-pump inhibitors (PPI), H2-receptor antagonists (H2RA), and antacids...
November 15, 2022: International Journal of Risk & Safety in Medicine
#3
JOURNAL ARTICLE
Kannan Sridharan, Shamik Shah, Ola Al Segai, Eman Mansoor, Mustafa Hamad, Eman Farid
BACKGROUND: Renal transplant patients receive several drugs concomitantly. OBJECTIVE: Limited literature exists evaluating the drug use in this population that is at high risk for drug-induced acute kidney injury and complications due to under-or over-dosage of immunosuppressant drugs due to drug-drug interactions. METHODS: A retrospective observational study was carried out in 269 renal transplant patients in whom either oral or parenteral drugs were evaluated...
November 15, 2022: International Journal of Risk & Safety in Medicine
#4
JOURNAL ARTICLE
Maria Luiza Rodrigues Dos Santos, Victória Brioso Tavares, Natália Silva da Costa, Marcos Valério Santos da Silva, João Simão de Melo-Neto
BACKGROUND: The COVID-19 pandemic highlighted the need for a new dynamic in the organization and practices of health services, as it required rapid restructuring to promote safe and harm-free assistance. OBJECTIVE: To assess the dimensions of the patient safety culture (PSC) from the perspective of the health team professionals in clinical-surgical ICU (G1) compared to a COVID-19 ICU (G2). METHODS: Cross-sectional, analytical, descriptive and inferential study, using the "Hospital Survey on Patient Safety Culture" questionnaire...
November 15, 2022: International Journal of Risk & Safety in Medicine
#5
(no author information available yet)
No abstract text is available yet for this article.
2022: Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine
#6
(no author information available yet)
No abstract text is available yet for this article.
2022: Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine
#7
JOURNAL ARTICLE
Zahra Ghaemi, Bahram M Soltani, Seyed Javad Mowla
BACKGROUND: ErbB/PI3K signaling is widely recognized as a critical modulator of malignancy and miRNAs have been found to play a crucial role in the regulation of this pathway. OBJECTIVE: This study aimed to identify novel miRNAs related to the ErbBs loci and investigate the functional effects of these miRNAs on ErbB/PI3K signaling in cancer progression. MATERIALS AND METHODS: Bioinformatics tools and RNA-seq data were used to discover novel miRNAs in breast and colon cancer cells...
2022: Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine
#8
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
November 29, 2022: Annals of Internal Medicine
#9
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
November 29, 2022: Annals of Internal Medicine
#10
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
November 29, 2022: Annals of Internal Medicine
#11
JOURNAL ARTICLE
Stephanie Chang
No abstract text is available yet for this article.
November 29, 2022: Annals of Internal Medicine
#12
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
November 29, 2022: Annals of Internal Medicine
#13
JOURNAL ARTICLE
Mark Loeb, Amy Bartholomew, Madiha Hashmi, Wadea Tarhuni, Mohamed Hassany, Ilan Youngster, Ranjani Somayaji, Oscar Larios, Joseph Kim, Bayan Missaghi, Joseph V Vayalumkal, Dominik Mertz, Zain Chagla, Maureen Cividino, Karim Ali, Sarah Mansour, Lana A Castellucci, Charles Frenette, Leighanne Parkes, Mark Downing, Matthew Muller, Verne Glavin, Jennifer Newton, Ravi Hookoom, Jerome A Leis, James Kinross, Stephanie Smith, Sayem Borhan, Pardeep Singh, Eleanor Pullenayegum, John Conly
BACKGROUND: It is uncertain if medical masks offer similar protection against COVID-19 compared with N95 respirators. OBJECTIVE: To determine whether medical masks are noninferior to N95 respirators to prevent COVID-19 in health care workers providing routine care. DESIGN: Multicenter, randomized, noninferiority trial. (ClinicalTrials.gov: NCT04296643). SETTING: 29 health care facilities in Canada, Israel, Pakistan, and Egypt from 4 May 2020 to 29 March 2022...
November 29, 2022: Annals of Internal Medicine
#14
JOURNAL ARTICLE
Gail E Potter, Tyler Bonnett, Kevin Rubenstein, David A Lindholm, Rekha R Rapaka, Sarah B Doernberg, David C Lye, Richard A Mularski, Noreen A Hynes, Susan Kline, Catharine I Paules, Cameron R Wolfe, Maria G Frank, Nadine G Rouphael, Gregory A Deye, Daniel A Sweeney, Rhonda E Colombo, Richard T Davey, Aneesh K Mehta, Jennifer A Whitaker, Jose G Castro, Alpesh N Amin, Christopher J Colombo, Corri B Levine, Mamta K Jain, Ryan C Maves, Vincent C Marconi, Robert Grossberg, Sameh Hozayen, Timothy H Burgess, Robert L Atmar, Anuradha Ganesan, Carlos A Gomez, Constance A Benson, Diego Lopez de Castilla, Neera Ahuja, Sarah L George, Seema U Nayak, Stuart H Cohen, Tahaniyat Lalani, William R Short, Nathaniel Erdmann, Kay M Tomashek, Pablo Tebas
BACKGROUND: The COVID-19 standard of care (SOC) evolved rapidly during 2020 and 2021, but its cumulative effect over time is unclear. OBJECTIVE: To evaluate whether recovery and mortality improved as SOC evolved, using data from ACTT (Adaptive COVID-19 Treatment Trial). DESIGN: ACTT is a series of phase 3, randomized, double-blind, placebo-controlled trials that evaluated COVID-19 therapeutics from February 2020 through May 2021. ACTT-1 compared remdesivir plus SOC to placebo plus SOC, and in ACTT-2 and ACTT-3, remdesivir plus SOC was the control group...
November 29, 2022: Annals of Internal Medicine
#15
JOURNAL ARTICLE
Mark É Czeisler, Charles A Czeisler
No abstract text is available yet for this article.
November 29, 2022: Annals of Internal Medicine
#16
JOURNAL ARTICLE
Amir Qaseem, Jennifer Yost, Matthew C Miller, Rebecca Andrews, Janet A Jokela, Mary Ann Forciea, George M Abraham, Linda L Humphrey
Description: Strategies to manage COVID-19 in the outpatient setting continue to evolve as new data emerge on SARS-CoV-2 variants and the availability of newer treatments. The Scientific Medical Policy Committee (SMPC) of the American College of Physicians (ACP) developed these living, rapid practice points to summarize the best available evidence on the treatment of adults with confirmed COVID-19 in an outpatient setting. These practice points do not evaluate COVID-19 treatments in the inpatient setting or adjunctive COVID-19 treatments in the outpatient setting...
November 29, 2022: Annals of Internal Medicine
#17
EDITORIAL
Robert A Kleinman, Thomas D Brothers, Nathaniel P Morris
No abstract text is available yet for this article.
November 29, 2022: Annals of Internal Medicine
#18
REVIEW
Haley K Holmer, Katherine Mackey, Celia V Fiordalisi, Mark Helfand
BACKGROUND: The durability of the antibody response after SARS-CoV-2 infection and the role of antibodies in protection against reinfection are unclear. PURPOSE: To synthesize evidence on the SARS-CoV-2 antibody response and reinfection risk with a focus on gaps identified in our prior reports. DATA SOURCES: MEDLINE (Ovid), EMBASE, CINAHL, World Health Organization Research Database, and reference lists from 16 December 2021 through 8 July 2022, with surveillance through 22 August 2022...
November 29, 2022: Annals of Internal Medicine
#19
JOURNAL ARTICLE
Todd C Lee, David R Boulware
No abstract text is available yet for this article.
November 29, 2022: Annals of Internal Medicine
#20
JOURNAL ARTICLE
Roger Chou
No abstract text is available yet for this article.
November 29, 2022: Annals of Internal Medicine
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
